Skip to main content
. 2020 Sep 29;12(10):2794. doi: 10.3390/cancers12102794
BCa bladder cancer
CXCL9 Chemokine, CXC motif, ligand 9
DSS disease-free survival
Fu recur follow up recurrence
KI67 Proliferation marker KI67
KRT5 Cytokeratin 5
KRT20 Cytokeratin 20
MIBC muscle invasive bladder cancer
NMIBC non-muscle invasive bladder cancer
OS overall survival
n.s. not significant
n.d. not determined
PD1 programmed cell death 1
PD-L1 programmed cell death ligand 1
PFS progression-free survival
pT pathological tumor stage
pN pathological lymph node stage
qRT-PCR quantitative real-time PCR
RFS recurrence-free survival